Skip to Main Content

Disclaimer »
Advertising

Shopping Cart
shopAAP
Shopping Cart
Create Account
Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination
Contents


Ecallantide

Basics

Name

Ecallantide

Pronunciation

(e KAL lan tide)

Brand Names: US

  • Kalbitor

Therapeutic Category

  • Kallikrein Inhibitor

Generic Availability (US)

No

Index Terms

  • DX-88

Clinical Pharmacology

Mechanism of Action

Ecallantide is a recombinant protein which inhibits the conversion of high molecular weight kininogen to bradykinin by selectively and reversibly inhibiting plasma kallikrein. Unregulated bradykinin production is thought to contribute to the increased vascular permeability and angioedema observed in HAE.
This item requires a subscription. For full access to this content, please log in to an existing user account or purchase an individual subscription. If you have an active subscription and appear logged in (your name appears in the upper right corner), but you cannot access content, please click the “Log Out” option under your name and log back in.
  • Online ISSN 2767-6617

Journals

Policy

Books

News

Solutions

First 1,000 Days Knowledge Center


Institutions/Librarians

Group Practices

Licensing/Permissions

Integrations

Advertising

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept